Antleron

Foundation date

2014

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices. By merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors we will accelerate the engineering of medicinal products, devices and processes that will change health care and result in a better life for all. The Antleron business philosophy is to create sustainable ventures through risk & reward sharing partnerships.

Upcoming events

Latest news

  • Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

    1 day ago

  • Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

    1 day ago

  • BISC Global opens in Switzerland

    Wednesday August 12th 2020